. Author manuscript; available in PMC: 2020 Oct 1.

Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Oct 1;82(2):202–210. doi: 10.1097/QAI.0000000000002122

Table 2:

Summary of baseline levels of urine biomarkers and eGFR in HIV-infected men in MACS, stratified by statin use^*

Biomarker	Statin user	Non-user	P-value
ACR, mg/g	7.4 (3.8, 18.5)	6.0 (3.5, 15.6)	<0.01
ACR > 30, mg/g	19%	18%	0.62
α1m, mg/dL	1.3 (0.7, 3.0)	1.5 (0.7, 3.3)	0.90
Detectable α1m	82%	84%	0.56
IL-18, pg/mL	32 (16, 58)	38 (17, 66)	0.25
KIM-1, pg/mL	604 (301, 1095)	645 (347, 1164)	0.17
PIIINP, ng/mL	6.6 (3.5, 12.0)	6.8 (3.9, 13.7)	0.95
eGFR, ml/min/1.73m²	90 (72, 101)	91 (77, 103)	0.14

Data are presented as Median (IQR) or numbers (percent).

Abbreviations: ACR, albumin-to-creatinine ratio; α1m, α-1-microglobulin; eGFR, estimated glomerular filtration rate; IL-18, interleukin 18; KIM-1, kidney injury molecule-1; PIIINP = pro-collagen type III N-terminal pro-peptide.

Estimates shown after applying inverse probability of treatment weights.